| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |